Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer.
Mansoor W, Joo S, Norquist JM, Kato K, Sun JM, Shah MA, Enzinger P, Adenis A, Doi T, Kojima T, Metges JP, Li Z, Kim SB, Cho BC, Sunpaweravong P, Alsina Maqueda M, Goekkurt E, Suryawanshi S, Shah S, Shen L.
Mansoor W, et al. Among authors: suryawanshi s.
Oncologist. 2024 May 30:oyae087. doi: 10.1093/oncolo/oyae087. Online ahead of print.
Oncologist. 2024.
PMID: 38815152
Free article.